4-Hydroxytamoxifen differentially exerts estrogenic and antiestrogenic effects on discrete subpopulations of human breast cancer cells

Author： Willard Scott Abrahman Elizabeth Faught William Leaumont David Frawley L.

Publisher： Humana Press, Inc

ISSN： 0969-711X

Source： Endocrine Journal, Vol.14, Iss.2, 2001-03, pp. : 247-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Functional heterogeneity within populations of breast cancer cells contribute to the seemingly paradoxical effects of antiestrogens and the development of antiestrogen “resistance.” Our objectives were to determine the degree to which T-47D cells may respond inappropriately (positively) to the antiestrogen 4-hydroxytamoxifen (HOT) alone, and whether all cells that respond to the stimulatory effects of estradiol-17β (E₂) are inhibited by the addition of HOT. Single, living T-47D cells were transfected by microinjection with an estrogen response element (ERE)-driven luciferase reporter plasmid. Transfected cells were then treated with medium alone, HOT, E₂ or a combination thereof on consecutive days, exposed to the substrate luciferin and subjected to quantification of photonic emissions reflective of ERE-stimulated activity. This analysis revealed a subpopulation of cells that exhibited increased ERE-driven photonic activity in response to HOT. In companion studies, E₂-stimulated ERE activity was reversed (on average) with HOT addition. However, analysis of individual cells revealed that although HOT reduced photonic activity in the majority (89.2%) of E₂-responsive cells, there was a small subset (10.8% of the population) that was stimulated by E₂ + HOT co-treatment. Our data support the hypothesis that these cells possess an intrinsic “resistance” to antiestrogenic agents, and that this could contribute to the remodeling of tumor cell populations toward a “resistant’ phenotype.